REFERENCES
- Bickers, D., Treatment of the Porphyrias: Mechanisms of Action, J Invest Dermatol 77(1):107-113, 1981.
- Watson, C. J., Hematin and Porphyria, editorial, N Engl J Med 293(12): 605-607, September 18, 1975.
- Lamon, J. M., Hematin Therapy for Acute Porphyria, Medicine 58(3): 252-269, 1979.
- Dhar, G J., et al., Effects of Hematin in Hepatic Porphyria, Ann Intern Med 83: 20-30, 1975.
- Watson, C. J., et al., Use of Hematin in the Acute Attack of the “Inducible” Hepatic Porphyrias, Adv Intern Med 23: 265-286, 1978.
- McColl, K. E., et al., Treatment with Haematin in Acute Hepatic Porphyria, Q J Med, New Series L (198): 161-174, Spring, 1981.
- Dhar, G. J., et al., Transitory Renal Failure Following Rapid Administration of a Relatively Large Amount of Hematin in a Patient with Acute Intermittent Porphyria in Clinical Remission, Acta Med Scand 203: 437-443, 1978.
- Morris, D.L., et al., Coagulopathy Associated with Hematin Treatment for Acute Intermittent Porphyria, Ann Intern Med 95: 700-701, 1981.
- Pierach, C. A., Hematin Therapy for the Porphyric Attack, Semin Liver Dis 2(2): 125-131, May, 1982.
Manufactured by: Fresenius Kabi USA, LLC Raleigh, NC 27616
For: Recordati Rare Diseases Inc. Lebanon, NJ 08833, U.S.A. U.S. Lic. No. 1899
RECORDATI RARE DISEASES GROUP ® Trademark of Recordati Rare Diseases Inc. Revised: February 2013
750-04243-7
|